CD33/Siglec-3 binding specificity, expression pattern, and consequences of gene deletion in mice

Molecular and Cellular Biology

Volumn 23, Issue 12, 2003, Pages 4199-4206

  Brinkman Van der Linden, Els C M ^a,d   Angata, Takashi ^a   Reynolds, Shirley A ^a,b,e   Powell, Leland D ^a,f   Hedrick, Stephen M ^a,b   Varki, Ajit ^a,c  

^a University of California San Diego   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Neose Technologies Inc   (United States)

^e UCSD MEDICAL CENTER   (United States)

^f OLIVE VIEW UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD33 ANTIGEN; EPITOPE; GLYCAN; INTERLEUKIN 6; LECTIN; MUCIN; PROTEIN; PROTEIN SIGLEC 3; SIALIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BONE MARROW; BONE MARROW CELL; CELL LINEAGE; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOKINE RELEASE; ERYTHROCYTE; GENE DELETION; GRANULOCYTE; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPECIES DIFFERENCE;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOTINYLATION; CASEINS; CELL LINEAGE; COS CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; EXONS; GENE DELETION; GRANULOCYTES; HEMATOPOIETIC STEM CELLS; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MODELS, GENETIC; N-ACETYLNEURAMINIC ACID; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS;

ANIMALIA; EUKARYOTA;

EID: 0038656361     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.12.4199-4206.2003     Document Type: Article

References (41)

1. Angata, T., and E. Brinkman-Van der Linden. 2002. I-type lectins. Biochim. Biophys. Acta 1572:294-316.
2. Angata, T., R. Hingorani, N. M. Varki, and A. Varki. 2001. Cloning and characterization of a novel mouse Siglec, mSiglec-F: differential evolution of the mouse and human (CD33) Siglec-3-related gene clusters. J. Biol. Chem. 276:45128-45136.
3. Angata, T., and A. Varki. 2000. Siglec-7: a sialic acid-binding lectin of the immunoglobulin superfamily. Glycobiology 10:431-438.
4. Angata, T., and A. Varki. 2000. Cloning, characterization, and phylogenetic analysis of Siglec-9, a new member of the CD33-related group of Siglecs-evidence for co-evolution with sialic acid synthesis pathways. J. Biol. Chem. 275:22127-22135.
5. Angata, T., and A. Varki. 2002. Chemical diversity in the sialic acids and related alpha-keto acids: an evolutionary perspective. Chem. Rev. 102:439-470.
6. Boldrick, J. C., A. A. Alizadeh, M. Diehn, S. Dudoit, C. L. Liu, C. E. Belcher, D. Botstein, L. M. Staudt, P. O. Brown, and D. A. Relman. 2002. Stereotyped and specific gene expression programs in human innate immune responses to bacteria. Proc. Natl. Acad. Sci. USA 99:972-977.
7. Brinkman-Van der Linden, E. C. M., and A. Varki. 2000. New aspects of siglec binding specificities, including the significance of fucosylation and of the sialyl-Tn epitope. J. Biol. Chem. 275:8625-8632.
8. Cornish, A. L., S. Freeman, G. Forbes, J. Ni, M. Zhang, M. Cepeda, R. Gentz, M. Augustus, K. C. Carter, and P. R. Crocker. 1998. Characterization of siglec-5, a novel glycoprotein expressed on myeloid cells related to CD33. Blood 92:2123-2132.
9. Crocker, P. R., and A. Varki. 2001. Siglecs, sialic acids and innate immunity. Trends Immunol. 22:337-342.
10. Crocker, P. R., and A. Varki. 2001. Siglecs in the immune system. Immunology 103:137-145.
11. Diaz, S., H. H. Higa, B. K. Hayes, and A. Varki. 1989. O-acetylation and de-O-acetylation of sialic acids. 7- and 9-O-acetylation of alpha2,6-linked sialic acids on endogenous N-linked glycans in rat liver Golgi vesicles. J. Biol. Chem. 264:19416-19426.
12. Dinarello, C. A. 1996. Cytokines as mediators in the pathogenesis of septic shock. Curr. Top. Microbiol. Immunol. 216:133-165.
13. Edelman, G. M., and J. A. Gally. 2001. Degeneracy and complexity in biological systems. Proc. Natl. Acad. Sci. USA 98:13763-13768.
14. Falco, M., R. Biassoni, C. Bottino, M. Vitale, S. Sivori, R. Augugliaro, L. Moretta, and A. Moretta. 1999. Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells. J. Exp. Med. 190:793-801.
15. Ferlazzo, G., G. M. Spaggiari, C. Semino, G. Melioli, and L. Moretta. 2000. Engagement of CD33 surface molecules prevents the generation of dendritic cells from both monocytes and CD34+ myeloid precursors. Eur. J. Immunol. 30:827-833.
16. Festing, M. F., E. M. Simpson, M. T. Davisson, and L. E. Mobraaten. 1999. Revised nomenclature for strain 129 mice. Mamm. Genome 10:836.
17. Floyd, H., J. Ni, A. L. Cornish, Z. Z. Zeng, D. Liu, K. C. Carter, J. Steel, and P. R. Crocker. 2000. Siglec-8 - a novel eosinophil-specific member of the immunoglobulin superfamily. J. Biol. Chem. 275:861-866.
18. Freeman, S. D., S. Kelm, E. K. Barber, and P. R. Crocker. 1995. Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules. Blood 85:2005-2012.
19. Hill, H. D. J., J. A. Reynolds, and R. L. Hill. 1977. Purification, composition, molecular weight, and subunit structure of ovine submaxillary mucin. J. Biol. Chem. 252:3791-3798.
20. Kelm, S., R. Brossmer, R. Isecke, H. J. Gross, K. Strenge, and R. Schauer. 1998. Functional groups of sialic acids involved in binding to siglecs (sialoadhesins) deduced from interactions with synthetic analogues. Eur. J. Biochem. 255:663-672.
21. Kelm, S., R. Schauer, J.-C. Manuguerra, H.-J. Gross, and P. R. Crocker. 1994. Modifications of cell surface sialic acids modulate cell adhesion mediated by sialoadhesin and CD22. Glycoconj. J. 11:576-585.
22. Klein, A., M. Krishna, N. M. Varki, and A. Varki. 1994. 9-O-acetylated sialic acids have widespread but selective expression: analysis using a chimeric dual-function probe derived from influenza C hemagglutinin-esterase. Proc. Natl. Acad. Sci. USA 91:7782-7786.
23. Lloyd, K. O., and A. Savage. 1991. High performance anion exchange chromatography of reduced oligosaccharides from sialomucins. Glycoconj. J. 8:493-498.
24. Manzi, A. E., A. Dell, P. Azadi, and A. Varki. 1990. Studies of naturally occurring modifications of sialic acids by fast-atom bombardment-mass spectrometry. Analysis of positional isomers by periodate cleavage. J. Biol. Chem. 265:8094-8107.
25. Nau, G. J., J. F. Richmond, A. Schlesinger, E. G. Jennings, E. S. Lander, and R. A. Young. 2002. Human macrophage activation programs induced by bacterial pathogens. Proc. Natl. Acad. Sci. USA 99:1503-1508.
26. Nicoll, G., J. Ni, D. Liu, P. Klenerman, J. Munday, S. Dubock, M. G. Mattei, and P. R. Crocker. 1999. Identification and characterization of a novel siglec, siglec-7, expressed by human natural killer cells and monocytes. J. Biol. Chem. 274:34089-34095.
27. Paul, S. P., L. S. Taylor, E. K. Stansbury, and D. W. McVicar. 2000. Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2. Blood 96:483-490.
28. Savage, A. V., C. M. Donoghue, S. M. D'Arcy, C. A. M. Koeleman, and D. H. Van den Eijnden. 1990. Structure determination of five sialylated trisaccharides with core types 1, 3 or 5 isolated from bovine submaxillary mucin. Eur. J. Biochem. 192:427-432.
29. Simpson, E. M., C. C. Linder, E. E. Sargent, M. T. Davisson, L. E. Mobraaten, and J. J. Sharp. 1997. Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nat. Genet. 16:19-27.
30. Sjoberg, E. R., L. D. Powell, A. Klein, and A. Varki. 1994. Natural ligands of the B cell adhesion molecule CD22beta can be masked by 9-O-acetylation of sialic acids. J. Cell Biol. 126:549-562.
31. Strenge, K., R. Schauer, N. Bovin, A. Hasegawa, H. Ishida, M. Kiso, and S. Kelm. 1998. Glycan specificity of myelin-associated glycoprotein and sialoadhesin deduced from interactions with synthetic oligosaccharides. Eur. J. Biochem. 258:677-685.
32. Taylor, V. C., C. D. Buckley, M. Douglas, A. J. Cody, D. L. Simmons, and S. D. Freeman. 1999. The myeloid-specific sialic acid-binding receptor, CD33, associates with the protein-tyrosine phosphatases, SHP-1 and SHP-2. J. Biol. Chem. 274:11505-11512.
33. Tchilian, E. Z., P. C. Beverley, B. D. Young, and S. M. Watt. 1994. Molecular cloning of two isoforms of the murine homolog of the myeloid CD33 antigen. Blood 83:3188-3198.
34. Threadgill, D. W., D. Yee, A. Matin, J. H. Nadeau, and T. Magnuson. 1997. Genealogy of the 129 inbred strains: 129/SvJ is a contaminated inbred strain. Mamm. Genome 8:390-393.
35. Tsuji, T., and T. Osawa. 1986. Carbohydrate structures of bovine submaxillary mucin. Carbohydr. Res. 151:391-402.
36. Ulyanova, T., J. Blasioli, T. A. Woodford-Thomas, and M. L. Thomas. 1999. The sialoadhesin CD33 is a myeloid-specific inhibitory receptor. Eur. J. Immunol. 29:3440-3449.
37. Van Halbeek, H., L. Dorland, J. Haverkamp, G. A. Veldink, J. F. Vliegenthart, B. Fournet, G. Ricart, J. Montreull, W. D. Gathmann, and D. Aminoff. 1981. Structure determination of oligosaccharides isolated from A+, H+ and A-, H- hog-submaxillary-gland mucin glycoproteins, by 360-MHz 1HNMR spectroscopy, permethylation analysis and mass spectrometry. Eur. J. Biochem. 118:487-495.
38. Varki, A. 1992. Diversity in the sialic acids. Glycobiology 2:25-40.
39. Vitale, C., C. Romagnani, M. Falco, M. Ponte, M. Vitale, A. Moretta, A. Bacigalupo, L. Moretta, and M. C. Mingari. 1999. Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells. Proc. Natl. Acad. Sci. USA 96:15091-15096.
40. Vitale, C., C. Romagnani, A. Puccetti, D. Olive, R. Costello, L. Chiossone, A. Pitto, A. Bacigalupo, L. Moretta, and M. C. Mingari. 2001. Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias: engagement of CD33 induces apoptosis of leukemic cells. Proc. Natl. Acad. Sci. USA 98:5764-5769.
41. Whitney, G., S. L. Wang, H. Chang, K. Y. Cheng, P. Lu, X. D. Zhou, W. P. Yang, M. McKinnon, and M. Longphre. 2001. A new siglec family member, siglec-10, is expressed in cells of the immune system and has signaling properties similar to CD33. Eur. J. Biochem. 268:6083-6096.